These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9861925)

  • 1. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R; Barker J
    N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously?
    van der Meché FG
    Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome.
    Kleyweg RP; van der Meché FG; Schmitz PI
    Transfus Sci; 1994 Dec; 15(4):389-92. PubMed ID: 10172508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M; Olivier J; Vivant JF
    Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange and i.v.-immunoglobulins: new approaches to the treatment of Guillain-Barre' syndrome.
    Fasanaro AM; Pizza V; Stella L
    Acta Neurol (Napoli); 1992; 14(4-6):369-80. PubMed ID: 1293980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guillain-Barré syndrome in children treated with intravenous immunoglobulin].
    Andersen UM
    Ugeskr Laeger; 1993 Oct; 155(42):3392-4. PubMed ID: 8259633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational therapy of Guillain-Barré syndrome.
    Raphael JC; Chevret S
    Lancet; 1998 Mar; 351(9104):753. PubMed ID: 9504542
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune mediated neuropathies--an update on therapeutic strategies.
    Czaplinski A; Steck AJ
    J Neurol; 2004 Feb; 251(2):127-37. PubMed ID: 14991345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immune globulin in the Guillain-Barré syndrome.
    van der Meché FG
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The number of plasma exchanges in Guillain-Barré syndrome: evaluation by the removal rate of immunoglobulin G].
    Tagawa Y; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1998; 38(10-11):951-4. PubMed ID: 10203982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.
    Kleyweg RP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):957-60. PubMed ID: 1800666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
    Ng KK; Howard RS; Hirsch NP; Miller DH
    Neurology; 1993 Dec; 43(12):2729; author reply 2730-1. PubMed ID: 8255495
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of intravenous immunoglobulins in Guillain-Barré syndrome].
    Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA
    Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of severe Guillain-Barré syndrome.
    Ng KK; Howard RS; Fish DR; Hirsch NP; Wiles CM; Murray NM; Miller DH
    QJM; 1995 Apr; 88(4):243-50. PubMed ID: 7796073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guillain-Barré syndrome in the adult: therapeutic aspects].
    Raphael JC; Cardinaud JP; Fourrier F; Guidet B; Perrotin D
    Schweiz Med Wochenschr; 1998 Sep; 128(39):1453-61. PubMed ID: 9793164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].
    Imai N; Miyata K; Terayama Y; Ishihara N
    Rinsho Shinkeigaku; 1997 Jun; 37(6):520-2. PubMed ID: 9366182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.